Lyndra Therapeutics to shut down after funding challengesnews2025-03-25T20:46:17+00:00March 25th, 2025|Endpoints News|
Ophthalmology startup Character Biosciences gets $93M for genetics-based approachnews2025-03-25T12:00:00+00:00March 25th, 2025|Endpoints News|
Hillstar Bio raises $67M for immunology drugsnews2025-03-25T10:30:49+00:00March 25th, 2025|Endpoints News|
Tempero Bio, led by ex-Novartis execs, gets $70M to reduce substance use disordersnews2025-03-24T11:00:29+00:00March 24th, 2025|Endpoints News|
Belgian biotech Augustine gets $85M for neuro and cardiometabolic pillsnews2025-03-24T06:00:50+00:00March 24th, 2025|Endpoints News|
SV Health Investors nabs $250M to fund dementia-focused biotechsnews2025-03-20T17:15:35+00:00March 20th, 2025|Endpoints News|
Visen Pharmaceuticals prices $86M Hong Kong IPOnews2025-03-20T16:40:24+00:00March 20th, 2025|Endpoints News|
Flagship’s Ampersand gets Eli Lilly’s support in $65M Series Bnews2025-03-19T11:00:50+00:00March 19th, 2025|Endpoints News|
CRISPR startup Arbor Biotechnologies raises $73.9M as it nears first trialnews2025-03-18T10:30:00+00:00March 18th, 2025|Endpoints News|
